India to United States: Clindamycin Export Trade Route
India has recorded 744 verified shipments of Clindamycin exported to United States, representing a combined trade value of $41.2M USD. This corridor is served by 20 active Indian exporters, with an average shipment value of $55.4K USD. The leading Indian exporter is ENCUBE ETHICALS PRIVATE LIMITED, which accounts for 34% of total export value with 225 shipments worth $14.0M USD. On the buying side, CARDINAL HEALTH is the largest importer in United States with $4.9M USD in purchases. The top 3 suppliers — ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together control 65% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Clindamycin corridor is one of India's established pharmaceutical export routes, with 744 shipments documented worth a combined $41.2M USD. The route is dominated by ENCUBE ETHICALS PRIVATE LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.
Across 20 active suppliers, the average shipment value stands at $55.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 30.7%, placing it at rank #13 among India's top clindamycin export destinations globally.
On the import side, key buyers of Indian clindamycin in United States include CARDINAL HEALTH, IPD, SC, USA, AUROLOGISTICS LLC (AUROBINDO PHARMA and 57 others. CARDINAL HEALTH is the single largest importer with 88 shipments valued at $4.9M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ4
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#13
- Annual growth+30.7%
- Demand growth+25.6%
- Regulatory ease90/100
Top 10 Indian Clindamycin Exporters to United States
Showing top 10 of 20 Indian suppliers exporting Clindamycin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ENCUBE ETHICALS PRIVATE LIMITED Avg $62.2K per shipment | 225 | $14.0M | 34.0% |
| 2 | AUROBINDO PHARMA LTD Avg $82.1K per shipment | 86 | $7.1M | 17.1% |
| 3 | AUROBINDO PHARMA LIMITED Avg $110.0K per shipment | 52 | $5.7M | 13.9% |
| 4 | MICRO LABS LIMITED Avg $59.3K per shipment | 71 | $4.2M | 10.2% |
| 5 | GLENMARK PHARMACEUTICALS LIMITED Avg $23.7K per shipment | 144 | $3.4M | 8.3% |
| 6 | ZYDUS LIFESCIENCES LIMITED Avg $32.6K per shipment | 63 | $2.1M | 5.0% |
| 7 | MYLAN LABORATORIES LIMITED Avg $138.7K per shipment | 13 | $1.8M | 4.4% |
| 8 | VIVIMED LIFE SCIENCES PRIVATE LIMITED Avg $47.2K per shipment | 11 | $518.8K | 1.3% |
| 9 | GLENMARK PHARMACEUTICALS LTD Avg $36.7K per shipment | 14 | $513.7K | 1.2% |
| 10 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $89.5K per shipment | 5 | $447.3K | 1.1% |
This table shows the top 10 of 20 Indian companies exporting clindamycin to United States, ranked by total trade value. The listed exporters are: ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MICRO LABS LIMITED, GLENMARK PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, MYLAN LABORATORIES LIMITED, VIVIMED LIFE SCIENCES PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LTD, AMNEAL PHARMACEUTICALS PRIVATE LIMITED. ENCUBE ETHICALS PRIVATE LIMITED is the dominant supplier with 225 shipments worth $14.0M USD, giving it a 34% market share. The top 3 suppliers together account for 65% of the total trade value on this route.
Showing top 10 of 20 total Indian exporters on the India to United States Clindamycin export route.
Top 10 Clindamycin Importers in United States
Showing top 10 of 60 known buyers in United States receiving Clindamycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian clindamycin in United States include CARDINAL HEALTH, IPD, SC, USA, AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, EVERSANA LIFE SCIENCE SERVICES, among 60 total buyers. The largest importer is CARDINAL HEALTH, accounting for $4.9M USD across 88 shipments — representing 12% of all clindamycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CARDINAL HEALTH | 88 | $4.9M | 11.9% |
| 2 | IPD, SC, USA | 60 | $4.6M | 11.2% |
| 3 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 52 | $4.4M | 10.7% |
| 4 | AUROLOGISTICS LLC AUROBINDO PHARM | 36 | $4.1M | 9.9% |
| 5 | EVERSANA LIFE SCIENCE SERVICES | 76 | $2.8M | 6.7% |
| 6 | EVERSANA LIFE SCIENCE SERVICES, LLC | 46 | $2.4M | 5.9% |
| 7 | EVERSANA LIFE SCIENCE SERVICES LLC | 26 | $1.8M | 4.4% |
| 8 | AIM RX 3PL, LLC | 40 | $1.6M | 4.0% |
| 9 | EVERSANA | 12 | $1.6M | 3.9% |
| 10 | AUROLOGISTICS LLC | 9 | $1.5M | 3.7% |
Showing top 10 of 60 Clindamycin importers in United States on this route.
Top 10 Clindamycin Formulations Imported by United States
Showing top 10 of 431 product formulations shipped on the India to United States Clindamycin route, ranked by trade value
United States imports a wide range of clindamycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MGCLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG 100'S — accounts for $955.4K USD across 4 shipments. There are 431 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MGCLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG 100'S | 4 | $955.4K | 2.3% |
| 2 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG) 100'SNOS | 12 | $847.5K | 2.1% |
| 3 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG) 100'S | 10 | $787.9K | 1.9% |
| 4 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300 MG)100'S | 5 | $664.0K | 1.6% |
| 5 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG | 1 | $628.7K | 1.5% |
| 6 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300MG 100S 97128X100S PACKS 9712800 NOS | 1 | $622.2K | 1.5% |
| 7 | CLINDAMYCIN PHOSPHATE TOPICAL LOTION, 1%,60ML B.NO. 5CW04,5CW05,5CW09,5CW07,5CW13,5CW08,5CW11,5CW10,5CW06 MFG DT. JAN 20 | 1 | $424.6K | 1.0% |
| 8 | CLINDAMYCIN HYDROCHLORIDE CAPSULES USP 300MG (100'S) (60648 X 100'S PACKS = 6064800 NOS) | 1 | $419.1K | 1.0% |
| 9 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG60720X100'S | 1 | $383.8K | 0.9% |
| 10 | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP,1% 60ML BATCH No.4BH135,4BH140,4BH137,4BH138,4BH136,4BH141,4BH134,4BH139 MFG | 2 | $357.1K | 0.9% |
Showing top 10 of 431 Clindamycin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 85%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 151 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's clindamycin exports to United States are driven primarily by a handful of large-scale manufacturers. ENCUBE ETHICALS PRIVATE LIMITED with 225 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 20 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together account for 65% of total trade value on this route. The average shipment value of $55.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as clindamycin hydrochloride capsules 300mg(clindamycin hydrochloride capsules usp300 mg) 100'snos and clindamycin hydrochloride capsules 300mg(clindamycin hydrochloride capsules usp300 mg) 100's, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CARDINAL HEALTH is the largest importer with 88 shipments worth $4.9M USD — representing 12% of all clindamycin imports from India on this route. A total of 60 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $41.2M
- Avg. Shipment
- $55.4K
- Suppliers
- 20
- Buyers
- 60
- Transit (Sea)
- ~34 days
- Annual Growth
- +30.7%
Related Analysis
Reverse Direction
United States → India — Clindamycin (Import)Other Clindamycin Routes
Unlock the Full India to United States Clindamycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 744 shipments on this route.
Frequently Asked Questions — India to United States Clindamycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Clindamycin to United States?
The leading Indian exporters of Clindamycin to United States are ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED. ENCUBE ETHICALS PRIVATE LIMITED holds the largest market share at approximately 34% of total trade value on this route.
Q What is the total value of Clindamycin exports from India to United States?
India exports Clindamycin to United States worth approximately $41.2M USD across 744 recorded shipments. The average value per shipment is $55.4K USD.
Q Which ports does India use to ship Clindamycin to United States?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 151 shipments. Indian exporters primarily use sea freight for this route, with 85% of shipments going by sea and 30% by air.
Q How long does shipping take from India to United States for Clindamycin?
The average transit time for Clindamycin shipments from India to United States is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Clindamycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.7% with demand growth tracking at 25.6%. The route is ranked #13 among India's top Clindamycin export destinations globally.
Q How many suppliers are active on the India to United States Clindamycin route?
There are currently 20 active Indian suppliers exporting Clindamycin to United States. The market is moderately concentrated with ENCUBE ETHICALS PRIVATE LIMITED accounting for 34% of total shipment value.
Q Who are the main importers of Clindamycin from India in United States?
The leading importers of Indian Clindamycin in United States include CARDINAL HEALTH, IPD, SC, USA, AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, EVERSANA LIFE SCIENCE SERVICES. CARDINAL HEALTH is the largest buyer with 88 shipments worth $4.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Clindamycin.
- 2.Supplier/Buyer Matching: 20 Indian exporters and 60 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 744 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
744 Verified Shipments
20 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists